ex vivo drug sensitivity assay
Showing 1 - 25 of >10,000
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
- Recurrent Childhood Acute Myeloid Leukemia
- +13 more
-
Miami, FloridaNicklaus Children's Hospital
Jan 18, 2023
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Ex Vivo Drug Response and Clinical Outcome in Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- Biological sample collection
-
Linz, Upper Austria, Austria
- +2 more
Sep 28, 2023
Rational Treatment Trials of Blood Cancer
Completed
- Hematologic Diseases
- Treatment
- ex-vivo drug response assay
-
Heidelberg, GermanyUniversity Hospital Heidelberg
Nov 30, 2021
Benign Brain Tumor, Malignant Brain Tumor Trial in Toronto, Seoul (cCeLL Ex Vivo)
Not yet recruiting
- Benign Brain Tumor
- Malignant Brain Tumor
- cCeLL Ex Vivo
-
Toronto, Ontario, Canada
- +3 more
Oct 18, 2023
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in
Completed
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Chemosensitivity Assay
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 29, 2022
Parkinson Disease Trial in France (Blood sample collection and an optional cerebrospinal fluid (CSF) collection, Blood sample
Completed
- Parkinson Disease
- Blood sample collection and an optional cerebrospinal fluid (CSF) collection
- Blood sample collection
-
La Tronche, France
- +3 more
Apr 19, 2023
Ex VIvo DEtermiNed Cancer Therapy
Recruiting
- Bladder Cancer
- +5 more
- Functional drug screen
-
Sheffield, South Yorkshire, United KingdomSheffield Teaching Hospitals NHS Foundation Trust
Jan 31, 2022
Assessment of Methadone Dose Taken Using Electrochemistry
Not yet recruiting
- Methadone Toxicity
- +4 more
- ISF extraction device 1
- +4 more
- (no location specified)
Aug 7, 2023
Drug Sensitivity and Mutation Profiling
Recruiting
- Ewing Sarcoma
- +6 more
-
Miami, FloridaNicklaus Children's Hospital
Aug 5, 2022
Metastatic Colorectal Cancer Trial in Oslo (Alectinib, Cetuximab, Crizotinib)
Recruiting
- Metastatic Colorectal Cancer
- Alectinib
- +16 more
-
Oslo, NorwayOslo University Hospital
Feb 10, 2023
AML Trial in Berne (Image-based ex-vivo drug screening platform (pharmacoscopy))
Recruiting
- AML
- Image-based ex-vivo drug screening platform (pharmacoscopy)
-
Berne, SwitzerlandDepartement of Medical Oncology, University Hospital Berne
Feb 8, 2023
Inhibitory Neurotransmission in the Human Epileptic Brain.
Recruiting
- Drug Resistant Epilepsy
- ex-vivo study
-
Pozzilli, Isernia, ItalyIRCCS INM Neuromed
Jul 29, 2022
Sickle Cell Disease Trial in Paris (DREPAGLOBE drug product)
Active, not recruiting
- Sickle Cell Disease
- DREPAGLOBE drug product
-
Paris, FranceDepartment of Biotherapy, Necker-Enfants Malades Hospital
Sep 26, 2022
Transfusion-dependent a-Thalassemia Trial (GMCN-508A Drug Product)
Not yet recruiting
- Transfusion-dependent α-Thalassemia
- GMCN-508A Drug Product
- (no location specified)
Feb 24, 2023
Refractory MDS Patients
Active, not recruiting
- Myelodysplastic Syndromes
-
Stanford, CaliforniaStanford MDS Center
Aug 1, 2022
Breast Cancer Trial in United States (KIBUR MICRODEVICE, anthracycline and taxane based chemo)
Active, not recruiting
- Breast Cancer
- KIBUR MICRODEVICE
- anthracycline and taxane based chemotherapy
-
Basking Ridge, New Jersey
- +5 more
Jun 20, 2022
Acute Myeloid Leukemia Trial in Copenhagen (Venetoclax)
Recruiting
- Acute Myeloid Leukemia
-
Copenhagen, DenmarkDepartment of Hematology, Rigshospitalet
Jun 21, 2022
AMR-DetecTool for the Diagnostic of MDR Bacterial Infections
Completed
- Bacterial Sensitivity Tests
- Antimicrobial Drug Resistance
- AMR LFIA Assay
-
Le Kremlin-Bicêtre, France
- +2 more
Jan 12, 2023
Transfusion Dependent Beta-Thalassemia Trial in Nanning (GMCN-508B (LentiRed))
Recruiting
- Transfusion Dependent Beta-Thalassemia
- GMCN-508B (LentiRed)
-
Nanning, Guangxi, ChinaThe affiliated hospital of guangxi medical university
Feb 28, 2023
Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency Trial in Paris (ARTEGENE drug product)
Not yet recruiting
- Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency
- ARTEGENE drug product
-
Paris, FranceDepartment of Pediatric Immunology, Hematology and Rheumatology
Sep 26, 2022
Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)
Recruiting
- Multiple Myeloma in Relapse
- Selinexor
- +4 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 31, 2023
Ovarian Cancer Trial in Rome (Tumor biopsy)
Recruiting
- Ovarian Cancer
- Tumor biopsy
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 2, 2023
AI R&D Tool in Adult Glioma and Other Primary Brain Tumours
Not yet recruiting
- Brain Tumor
- +4 more
- Resection
-
London, United KingdomImperial College Healthcare NHS Trust
Sep 15, 2023